Letter: Tobramycin/cephalothin nephrotoxicity. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Letter: Tobramycin/cephalothin nephrotoxicity.

P Gillett, R Wise, V Melikian, R Falk

Author Information

PMID: 55831 DOI: 10.1016/s0140-6736(76)90347-0

No abstract text available.

Acute Kidney Injury

Anti-Bacterial Agents

Cephalothin

Drug Synergism

Drug Therapy, Combination

Humans

Tobramycin

Anti-Bacterial Agents

Cephalothin

Tobramycin

Journal Article

Letter: Gentamicin and cephalothin nephrotoxicity.[Nephrotoxicity of gentamycin and tobramycin combined with methicillin or cephalothin].Letter: Severe renal dysfunction after tobramycin/cephalothin therapy.[Empirical utilization of antibiotic combinations (ticarcillin-tobramycin, cephalothin-tobramycin and ticarcillin-cephalothin). A preliminary study].Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin.Nephrotoxicity associated with cephalothin administration.Nephrotoxicity of cephalothin-aminoglycoside interactions.Cephalothin-tobramycin as a preventive antibiotic combination.Nephrotoxicity with gentamicin or tobramycin.Ceftriaxone protects against tobramycin nephrotoxicity.